Delivery Order SPE2DB20D3103-SPE2DB24FM0E9

Award Date 12/21/23
Potential Completion Date 12/22/23
Potential Value $6.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 20,000 unit vials of the pharmaceutical product Thrombin-JMI. The firm fixed price contract has a potential value of $1,976.00 and a completion date of January 18, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from the DLA to provide pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,765.48 firm fixed-price delivery order is for the supply of 20,000-unit vials of the drug Thrombin-JMI. The contract has an ultimate completion date of November 30, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 20,000 unit vials of Thrombin-JMI. The $3,297.84 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The Defense Logistics Agency awarded a $323,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5,000 vials of Thrombin-JMI. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 17, 2023 in support of the Department of Defense's medical supply needs. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to...
This federal contract award, valued at $7,902.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of Thrombin-JMI, a medical product, with a performance period ending on January 31, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $14,373.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the drug Thrombin-JMI, which is used for various medical applications. The contract is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of January 22, 2025. This contract award is part of a larger...
<p>Amerisourcebergen Drug Corp has been awarded a six hundred forty-seven dollar firm fixed price delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency. The delivery order is for five thousand units of Thrombin-JMI five thousand units vials with an anticipated completion date of October 19, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.</p>
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 20,000 unit vials of the pharmaceutical product RECOTHROM. The $17,797.92 delivery order is part of a larger indefinite delivery contract, with an unspecified potential value, between Amerisourcebergen Drug Corp and DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 20,000 unit vials of the pharmaceutical product RECOTHROM. The $6,938.04 award has a completion date of January 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,714.81 delivery order is for RECOTHROM 20,000 unit vials and has a firm fixed price. The award has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM0E9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 20,000 unit vials of THROMBIN-JMI, a pharmaceutical product. The $6,595.68 delivery order has a completion date of December 22, 2023 and was issued without any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. No additional major subcontractors were mentioned.

Generated 3/21/24, 9:54 AM